Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...

Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...

Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of ...

Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...

EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for conditions ...